冠心病冠脉介入术后再狭窄的中医药防治进展  

Progress on Prevention and Treatment of Coronary Restenosis of Coronary Heart Disease with Traditional Chinese Medicine After Interventional Therapy

作　　者：郜俊清[1] 赵德强[1] 金惠根[1] 

机构地区：[1]上海中医药大学附属普陀医院心内科,上海200062

出　　处：《上海中医药大学学报》2009年第1期83-86,共4页Academic Journal of Shanghai University of Traditional Chinese Medicine

基　　金：上海市医学重点专科资助项目(05-Ⅱ026);上海市卫生局青年科研基金资助项目(2006Y063)

摘　　要：冠心病介入治疗,因其能迅速开通闭塞血管而在临床上取得了较满意的效果。然而,冠脉支架置入后,仍然存在发生再狭窄的可能性,影响了介入治疗的远期疗效。近年来,开展再狭窄的中医药预防研究取得了一定的进展。本文分别对再狭窄的中医病机认识以及中医药作用机制研究情况进行综述。For opening the blocked artery quickly, the interventional therapy has acquired satisfactory effects on the clincial treatment of coronary heart disease. However, the underlying risk of restenosis affected the therapeutic effect of interventional therapy in the long run. In recent years, some progress has been made in the prevention and treatment of restenosis with traditional Chinese medicine （TCM）. This article reviews the pathogenesis and mechanism research of TCM in the prevention and treatment of restenosis.

关 键 词：冠心病 介入治疗 再狭窄 中医药 综述 

分 类 号：R541.4[医药卫生—心血管疾病] R256.22[医药卫生—内科学]